olivlawolivlaw

olivLaw · European equity research

Tate & Lyle PLC TATE.L

United Kingdom · London Stock Exchange · ISIN GB00BP92CJ43 · Vertical: Listed companies from United Kingdom

5.62GBP−0.53% · 1 dayClose 05 Nov 2026

Tate & Lyle is a specialty ingredients supplier providing sweetening, mouthfeel and fortification solutions for food and beverages. After combining with CP Kelco, the company aims to accelerate growth in fast-growing markets in Asia, the Middle East, Africa and Latin America, amid rising demand for healthier food.

At the close of 05 Nov 2026, Tate & Lyle PLC (TATE.L) stock was 5.62 GBP (−0.53% on the day), with market capitalisation 2.5 bn GBP, P/E 25.9 on diluted EPS of 0.22 GBP over the last 12 months, dividend yield 3.55%, beta 0.25, 52-week range 3.29–5.69 GBP.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
2.5 bn GBP
shares as of 31 Mar 2026
P/E (TTM)
25.9
Diluted EPS TTM 0.22 · TTM to 31 Mar 2026
E/P (TTM)
3.86%
TTM to 31 Mar 2026
Dividend yield
3.55%
DPS 12m 0.20
Beta (2y)
0.25
Volatility (1y) 45%
52-week range
3.295.69

Price history

Loading chart…

Technical reading

RSI (14)
48.9
neutral
Bollinger (20, 2)
5.60 – 5.67
in the lower half of the band · %B 0.27 · band width 1.1%
SMA 50 / 200
5.60 / 4.72
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
0.01 / 0.01
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month+0.2%−0.6%+0.8 pp—
3 months+1.4%−4.2%+5.6 pp—
6 months+51.3%+4.3%+46.9 pp—
Year to date+49.9%+7.5%+42.4 pp—
1 year+48.7%+9.9%+38.8 pp+5.8%
3 years−11.1%+49.8%−60.9 pp+26.3%
5 years−28.6%+42.8%−71.4 pp—
Max drawdown (1y)
−19.1%
13 Feb 2026 → 20 Mar 2026
Max drawdown (5y)
−63.7%
29 Apr 2022 → 20 Mar 2026
Compound annual growth (5y)
−6.5%
EURO STOXX 50 +7.4%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 100 percentile of its own 3-quarter history (min 13.3, median 15.0, max 16.7; quarters with earnings only).

Fiscal years

Fiscal year202420252026
Revenue1.6 bn1.7 bn2.0 bn
Revenue YoYunavailable+5.4%+15.6%
Net income188.0 m143.0 m97.0 m
Net income YoYunavailable−23.9%−32.2%
Diluted EPS0.470.350.22
Diluted EPS YoYunavailable−25.8%−37.1%
net %11.4%8.2%4.8%
Free cash flow107.0 m50.0 m114.0 m

Balance sheet & financial health

Fiscal year 2026 · 31 Mar 2026

Cash
344.0 m GBP
Financial debt
1.3 bn GBP
Net debt
950.0 m GBP
Equity
1.6 bn GBP
Total assets
3.7 bn GBP
Debt / equity
0.81x
Current ratio
2.71x
ROE
6.1%
ROA
2.6%
FCF margin
5.7%

Financial statements (source on every figure)

Revenue and net income (GBP)

Margins

Income statement · GBP

Revenue
2024
1.6 bn
2025
1.7 bn
2026
2.0 bn

esef· 11 Jun 2026verified

Operating income
2024
207.0 m
2025
106.0 m
2026
180.0 m

esef· 11 Jun 2026verified

Interest expense
2024
25.0 m
2025
38.0 m
2026
57.0 m

esef· 11 Jun 2026verified

Pre-tax income
2024
201.0 m
2025
88.0 m
2026
131.0 m

esef· 11 Jun 2026verified

Income tax
2024
41.0 m
2025
43.0 m
2026
33.0 m

esef· 11 Jun 2026verified

Net income
2024
188.0 m
2025
143.0 m
2026
97.0 m

esef· 11 Jun 2026verified

Diluted EPS
2024
0.47
2025
0.35
2026
0.22

esef· 11 Jun 2026verified

Dividend per share
2024
0.19
2025
0.20
2026
0.20

esef· 11 Jun 2026derived

Balance sheet · GBP

Cash
2024
437.0 m
2025
334.0 m
2026
344.0 m

esef· 11 Jun 2026verified

Receivables
2024
294.0 m
2025
390.0 m
2026
408.0 m

esef· 11 Jun 2026verified

Inventories
2024
353.0 m
2025
560.0 m
2026
572.0 m

esef· 11 Jun 2026verified

Current assets
2024
1.1 bn
2025
1.3 bn
2026
1.3 bn

esef· 11 Jun 2026verified

Property, plant & equipment, net
2024
528.0 m
2025
1.4 bn
2026
1.4 bn

esef· 11 Jun 2026verified

Goodwill
2024
—
2025
542.0 m
2026
540.0 m

esef· 11 Jun 2026verified

Intangibles (excl. goodwill)
2024
—
2025
299.0 m
2026
254.0 m

esef· 11 Jun 2026verified

Total assets
2024
2.3 bn
2025
3.7 bn
2026
3.7 bn

esef· 11 Jun 2026verified

Accounts payable
2024
259.0 m
2025
369.0 m
2026
373.0 m

esef· 11 Jun 2026verified

Short-term debt
2024
17.0 m
2025
161.0 m
2026
20.0 m

esef· 11 Jun 2026verified

Long-term debt
2024
573.0 m
2025
1.1 bn
2026
1.3 bn

esef· 11 Jun 2026verified

Current liabilities
2024
338.0 m
2025
611.0 m
2026
493.0 m

esef· 11 Jun 2026verified

Total liabilities
2024
1.0 bn
2025
2.1 bn
2026
2.1 bn

esef· 11 Jun 2026verified

Equity
2024
1.2 bn
2025
1.6 bn
2026
1.6 bn

esef· 11 Jun 2026verified

Shares outstanding at year end
2024
397.5 m
2025
408.6 m
2026
440.9 m

esef· 11 Jun 2026derived

Cash flow · GBP

Operating cash flow
2024
208.0 m
2025
164.0 m
2026
230.0 m

esef· 11 Jun 2026verified

Capex
2024
101.0 m
2025
114.0 m
2026
116.0 m

esef· 11 Jun 2026verified

Free cash flow
2024
107.0 m ≈
2025
50.0 m ≈
2026
114.0 m ≈

esef· 11 Jun 2026derived

Investing cash flow
2024
-20.0 m
2025
-630.0 m
2026
-113.0 m

esef· 11 Jun 2026verified

Financing cash flow
2024
-215.0 m
2025
367.0 m
2026
-106.0 m

esef· 11 Jun 2026verified

Dividends paid
2024
76.0 m
2025
80.0 m
2026
88.0 m

esef· 11 Jun 2026verified

Computed indicators

Growth

Revenue growth (YoY)
15.6%
computed by olivLawFY 2026
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
69.8%
computed by olivLawFY 2026
Net income growth (YoY)
-32.2%
computed by olivLawFY 2026
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
-37.1%
computed by olivLawFY 2026
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
128.0%
computed by olivLawFY 2026

Profitability

Gross margin
unavailable
input data missing
EBITDA margin
unavailable
input data missing
EBIT margin
9.0%
computed by olivLawFY 2026
Net margin
4.8%
computed by olivLawFY 2026
FCF margin
5.7%
computed by olivLawFY 2026

Returns

ROE
6.1%
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
ROA
2.6%
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
ROIC
5.3%
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
ROCE
5.7%
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
Payout ratio (EPS)
92.0%
computed by olivLawFY 2026
Payout ratio (FCF)
77.2%
computed by olivLawFY 2026

Balance sheet

Net debt
950.0 m GBP
computed by olivLawbalance sheet at 31 Mar 2026
Net debt / EBITDA
unavailable
input data missing
Debt / equity
0.8x
computed by olivLawbalance sheet at 31 Mar 2026
Interest coverage
3.2x
computed by olivLawFY 2026

Liquidity

Current ratio
2.7x
computed by olivLawbalance sheet at 31 Mar 2026
Quick ratio
1.5x
computed by olivLawbalance sheet at 31 Mar 2026
Cash ratio
0.7x
computed by olivLawbalance sheet at 31 Mar 2026

Cash

Operating cash flow
230.0 m GBP
computed by olivLawFY 2026
Capital expenditure
116.0 m GBP
computed by olivLawFY 2026
Free cash flow
114.0 m GBP
computed by olivLawFY 2026
FCF conversion
117.5%
computed by olivLawFY 2026
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
73 days
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
Days inventory outstanding
unavailable
input data missing
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
2.5 bn GBP
computed by olivLawbalance sheet at 31 Mar 2026
Enterprise value
3.4 bn GBP
computed by olivLawbalance sheet at 31 Mar 2026
Market cap / net income TTM
25.5x
computed by olivLawFY 2026
P/E (TTM)
25.9x
computed by olivLawFY 2026
Earnings yield
3.9%
computed by olivLawFY 2026
P/B
1.6x
computed by olivLawbalance sheet at 31 Mar 2026
P/S
1.2x
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
EV/EBITDA
unavailable
input data missing
EV/EBIT
19.0x
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
EV/Sales
1.7x
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
P/FCF
21.7x
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
FCF yield
4.6%
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
Dividend yield
3.6%
computed by olivLawFY 2026
Shareholder yield (distributions)
3.6%
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Neutral profile

Score: 46 / 100

A scoring methodology on indicators and valuation, not investment advice.

Closing price

5.62 GBP

05 Nov 2026Source: olivLaw, closing series

Market cap: 2.5 bn GBP

Key indicators

Market capitalisation
2.5 bn GBP
computed by olivLawbalance sheet at 31 Mar 2026
P/E (TTM)
25.9x
computed by olivLawFY 2026
P/B
1.6x
computed by olivLawbalance sheet at 31 Mar 2026
EV/EBITDA
unavailable
input data missing
ROE
6.1%
computed by olivLawFY 2026 · balance sheet at 31 Mar 2026
Net margin
4.8%
computed by olivLawFY 2026
Revenue growth (YoY)
15.6%
computed by olivLawFY 2026
Dividend yield
3.6%
computed by olivLawFY 2026

Coverage and freshness

29/37 reporting lines present
Latest full fiscal year: 2026
Latest reported period: 31 Mar 2026
Latest balance sheet date: 31 Mar 2026
Share count (cover of the latest filing), as of: 31 Mar 2026
Source: esefpublished 11 Jun 2026
verified 87derived 6

Score by group

  • Quality49
  • Returns55
  • Balance sheet55
  • Valuation32

Estimated value range

unavailable — no valuation assumptions for the reporting currency

Valuation assumptions are editorial choices, not measured; beta is not measured.

Valuation methods

    Assumptions (illustrative, editorial)

    Risk-free rate
    6.5%
    Equity risk premium
    6.0%
    Beta (default)
    1.00
    Cost of equity
    12.5%
    Terminal growth
    3.0%

    Factor scorecard

    Neutral profile · Score 46/100

    FactorValueScoreWeight used
    ROIC · Quality5.3%25 (vs peers)17%
    Net margin · Quality4.8%37 (vs peers)10%
    FCF conversion · Quality117.5%100 (on a fixed band)10%
    Revenue CAGR 3Y · Growthunavailableunavailable—
    EPS CAGR 3Y · Growthunavailableunavailable—
    Net debt / EBITDA · Balance sheetunavailableunavailable—
    Interest coverage · Balance sheet3.2x26 (on a fixed band)10%
    Current ratio · Balance sheet2.7x100 (on a fixed band)7%
    P/E (TTM) · Valuation25.9x11 (vs peers)17%
    EV/EBITDA · Valuationunavailableunavailable—
    FCF yield · Valuation4.6%58 (on a fixed band)13%
    Shareholder yield (distributions) · Returns3.6%51 (on a fixed band)10%
    Payout ratio (FCF) · Returns77.2%61 (on a fixed band)7%

    Factors without a value were dropped; the remaining weights were renormalised.

    Score groups

    • Balance sheet55/100 · 2/3 factors with a value
    • Growth· partialunavailable · 0/2 factors with a value
    • Quality49/100 · 3/3 factors with a value
    • Returns55/100 · 2/2 factors with a value
    • Valuation32/100 · 2/3 factors with a value

    A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

    Memo

    TATE & LYLE PUBLIC LIMITED COMPANY (TATE.L). Latest full fiscal year: 2026; data up to 2026-03-31.

    Figures computed from the financial statements: revenue 2.0 bn GBP in 2026; YoY growth 15.6%; net margin 4.8%; ROE 6.1%.

    The estimated value range is 2.45–3.78 GBP per share (median of 3 methods, agreement: low); assumptions are illustrative. Against the central value of 3.13 GBP, the price of 5.62 GBP leaves a potential of -44.3% (value / price − 1) and a margin of safety of -79.5% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

    olivLaw score 46/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: growth. Not investment advice.

    Text generated deterministically from the figures shown; no language model. Not investment advice.

    What supports the thesis

    • FCF conversion: 117.5%
    • Current ratio: 2.7x

    What contradicts it

    • ROIC: 5.3%
    • Interest coverage: 3.2x
    • P/E (TTM): 25.9x
    • The price is above the estimated value range
    • The valuation methods diverge

    Not assessed (insufficient data or a ratio without meaning): Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA.

    Versus the vertical median

    Listed companies from United Kingdom · same country · compared with 39 companies

    Multiples and returns vs the median

    P/E
    25.9x
    vertical median 15.3x
    above median (+68.8%)
    EV/EBITDA
    —
    vertical median —
    P/S
    1.2x
    vertical median 1.5x
    below median (−19.6%)
    P/B
    1.6x
    vertical median 2.2x
    below median (−28.2%)
    ROE
    6.1%
    vertical median 14.4%
    below median (−57.6%)
    Net margin
    4.8%
    vertical median 10.8%
    below median (−55.1%)
    EBIT margin
    9.0%
    vertical median 22.9%
    below median (−60.9%)
    Revenue YoY
    15.6%
    vertical median 7.9%
    above median (+97.4%)
    Net debt/EBITDA
    —
    vertical median —
    Dividend yield
    3.6%
    vertical median 2.9%
    above median (+24.3%)

    Price rebased to 100 (monthly, 5 years)

    Companies in the vertical

    Market capP/EROENet marginRevenue YoY1A / 3A
    BATS.LBritish American Tobacco P.L.C.104.3 bn13.516.5%30.3%−1.0%+7% / +88%
    ABF.LAssociated British Foods PLC14.7 bn14.39.2%5.3%−3.1%−5% / −15%
    0EV1.LCarnival PLC5.5 bn4.146.7%13.4%+6.4%unavailable / unavailable
    BAB.LBabcock International Group PLC5.1 bn24.734.7%4.1%+7.2%−10% / +158%
    AUTO.LAutotrader Group PLC4.8 bn16.460.2%47.1%+3.9%−13% / −23%
    BBY.LBalfour Beatty PLC4.2 bn16.323.2%2.8%+15.2%+20% / +160%
    ABDN.LAberdeen Group PLC4.1 bn10.88.0%28.9%−2.1%+11% / +41%
    BKG.LThe Berkeley Group Holdings PLC3.6 bn11.38.8%13.4%−4.2%−0% / −22%
    BME.LB&M European Value Retail PLC2.9 bn17.421.2%2.8%+3.7%+68% / −51%
    TATE.LTate & Lyle Public Limited Company2.5 bn25.96.1%4.8%+15.6%+50% / −9%
    AJB.LAj Bell PLC2.4 bn22.849.9%33.1%+18.0%+8% / +128%
    ASHM.LAshmore Group PLC1.4 bn13.913.1%71.6%−0.1%+28% / +18%
    BCG.LBaltic Classifieds Group PLC1.2 bn23.215.8%57.6%+6.9%−99% / −99%
    APN.LApplied Nutrition PLC763.6 m36.241.2%19.7%+24.2%+71% / unavailable
    BAG.LA.G. Barr P.L.C.671.9 m14.414.4%10.8%+4.0%−7% / +26%
    ASC.LAsos PLC494.5 m—-81.3%-12.0%−14.7%+71% / +8%
    ALFA.LAlfa Financial Software Holdings PLC486.8 m16.361.5%23.8%+15.3%−28% / +10%
    AML.LAston Martin Lagonda Global Holdings PLC344.3 m—-93.4%-39.2%−20.6%−45% / −85%
    APTD.LAptitude Software Group PLC111.3 m28.57.2%6.2%−7.3%−30% / −23%
    AMGO.LAmigo Holdings PLC9.9 m———−81.9%+325% / +844%
    ASBE.LAssociated British Engineering PLC605.3 k—-19.1%—unavailableunavailable / unavailable
    AMIF.LAmicorp Fs (uk) PLC221.6 k0.127.5%9.1%+8.1%unavailable / unavailable
    AAF.LAirtel Africa PLC——24.1%10.6%+29.5%−7% / +164%
    AAL.LAnglo American PLC——-19.3%-20.2%+4.5%+30% / +76%
    ACG.LAcg Metals Limited——-80.3%-32.0%+134.8%+60% / +63%

    1- and 3-year price returns: for TATE.L from daily closes (the same as the performance table), for the other companies from month-end closes.

    olivLaw engine forecast

    The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

    The engine has no published run for this company yet.

    Valuation scenarios (editable assumptions)

    Illustrative scenarios

    Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

    Bear
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Base
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Bull
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Nothing is saved.

    Estimated price (GBP)

    Estimated priceBearBaseBull
    1 years
    3.72
    Total return -31% · Per year -31%
    6.55
    Total return 21% · Per year 21%
    9.83
    Total return 80% · Per year 80%
    3 years
    4.42
    Total return -11% · Per year -4%
    8.67
    Total return 69% · Per year 19%
    14.15
    Total return 170% · Per year 39%
    5 years
    5.24
    Total return 12% · Per year 2%
    11.46
    Total return 132% · Per year 18%
    20.38
    Total return 300% · Per year 32%
    What moves the 3-year price the most
    • Exit P/E± 2.17
    • Net margin± 1.52
    • Annual revenue growth± 1.13
    • Annual dilution± 0.13

    AI analysis

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    In brief

    Tate & Lyle is a specialty ingredients supplier providing sweetening, mouthfeel and fortification solutions for food and beverages. After combining with CP Kelco, the company aims to accelerate growth in fast-growing markets in Asia, the Middle East, Africa and Latin America, amid rising demand for healthier food 1.

    SWOT

    Strengths

    • The company holds a leading position in sweetening and fibre ingredients, backed by more than a century of scientific experience 1.
    • The integrated portfolio of sweetening, mouthfeel and fortification allows complex reformulations for customers 1.
    • The combination with CP Kelco brought new ingredients and access to additional categories 1.

    Weaknesses

    • Integrating the two organisations has brought significant change and pressure on teams 1.
    • The fortification platform is still small relative to the rest of the business 1.
    • The company has set a goal of returning to top-line growth, which signals a recent challenge 1.

    Opportunities

    • Markets in Asia, the Middle East, Africa and Latin America offer strong growth potential 1.
    • Demand for foods with fewer calories and more fibre could support reformulation work 1.
    • Replacing sugar in the global sweetening market remains a major opportunity 1.

    Threats

    • Cost pressure on consumers may reduce willingness to pay for premium ingredients 1.
    • Rules on labelling and ultra-processed foods could shift demand 1.
    • Competition from suppliers of similar solutions could limit margin growth 1.

    Risks

    • Integration after the CP Kelco combinationmedium

      Integrating operations and systems could delay expected benefits and affect employees 1.

    • Return to sales growthhigh

      If the return to top-line growth is delayed, the growth strategy could be questioned 1.

    • Water and natural resource risksmedium

      Sourcing raw materials and processing them in water-stressed areas can create operational and regulatory risks 1.

    • Product safetymedium

      Breaches of product safety standards could harm consumers and create legal risk 1.

    • Employee engagementlow

      If employees are not sufficiently engaged, retention and operational stability could be affected 1.

    Investment thesis

    What would need to be true (bull case)

    • If demand for healthier food keeps growing, the integrated sweetening, mouthfeel and fortification portfolio could support growth 1.
    • Its leading position in sweetening and fibre ingredients, backed by long scientific expertise, could give it a competitive edge 1.
    • Integrating CP Kelco could open access to new categories and higher-value ingredients 1.

    What would break the thesis

    • If the return to top-line growth is delayed, investors could see more uncertainty than progress in the strategy 1.
    • Integrating the two companies could slow execution and reduce productivity if the changes are prolonged 1.
    • Cost pressure on consumers could limit customers' willingness to adopt more expensive ingredients 1.

    What to watch

    • Progress of the CP Kelco integration and organisational structure2027
    • Demand trends for fibre and fortification in emerging markets2027
    • Impact of labelling rules and ultra-processed food regulation2027

    Products, market & competition

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    The business

    Tate & Lyle bases its strategy on three platforms: sweetening, mouthfeel and fortification, aiming to reformulate foods to cut sugar and calories and add fibre and protein without compromising taste or texture 1. The company operates in four core categories: beverage, dairy, soups, sauces and dressings, and bakery and snacks 1. Since April 2025, Tate & Lyle and CP Kelco operate as one company, with new values and an integrated structure 1.

    The company describes a growth model combining scientific expertise, solutions capability, global supply chain and culture, all focused on customers 1. The strategy includes portfolio expansion, accelerated innovation, market focus and integrated solutions, with customers involved early in product development 1. To respond faster to regional needs, it uses a chassis approach in which a global base is adapted locally 1.

    The company has set a priority of returning the business to top-line growth, as stated in its internal reporting after the financial year end 1. The integration of the two companies involves organisational change, and objectives for the coming year were set with the top leadership team 1.

    Segments

    Sweetening

    The sweetening platform combines non-nutritive sweeteners, functional sugars and lower-calorie alternatives to reduce sugar without losing taste 1. The addressable market for sweetening ingredients is estimated at around 6 billion USD, and the largest opportunity lies in replacing traditional sugar 1.

    Mouthfeel

    This platform focuses on the texture and mouth sensation of food, using pectins, gums and starches to maintain product quality when sugar, fat or costs are reduced 1. The company estimates an addressable market of around 11 billion USD for this platform 1.

    Fortification

    The fortification platform includes dietary fibres and a small amount of chickpea plant protein, aiming to close the fibre gap in consumers' diets 1. The estimated addressable market is around 3 billion USD, and the business is still small relative to the rest of the company 1.

    Market context

    The company estimates the global speciality food ingredient market is worth 70 billion USD, of which 20 billion USD is addressable by its platforms 1. Most of the addressable market is in Asia, the Middle East, Africa and Latin America, with Asia at 36% and North America at 23% 1. Demand for healthier food with less sugar and more fibre is a key structural factor, supported by growing use of GLP-1 medications 1.

    The market is also shaped by stricter labelling rules and reformulation pressure, as well as concerns about ultra-processed foods 1. Industry players are accelerating reformulation, which could create opportunities for Tate & Lyle's ingredients if demand holds 1.

    Trends

    • Consumers seeking healthier foodtailwind

      Consumers increasingly want foods with less sugar, calories and fat and more fibre and protein, a strong structural trend 1. If this demand continues, it could support growth in reformulation segments 1.

    • GLP-1 medications and diet changetailwind

      Growing use of GLP-1 weight-management medications reduces appetite, so food needs to be more nutritionally dense 1. This could support demand for fortification ingredients if the trend continues 1.

    • Cost pressure on consumersmixed

      The cost-of-living crisis makes value for money a key purchasing factor, pushing manufacturers to seek cheaper solutions 1. This context can create price pressure but also opportunities for cost-optimising solutions 1.

    • Transparency and natural ingredientsmixed

      Consumers ask for transparency about ingredients and origin, and demand for plant-based food is rising 1. This could favour natural ingredients but also raises compliance standards 1.

    Competitive position

    The speciality ingredients market is competitive, and Tate & Lyle differentiates itself by combining sweetening, mouthfeel and fortification expertise with integrated formulation capability 1. The source does not explicitly name competitors, so this analysis relies on the market structure described by the company 1.

    The company's edge lies in more than a century of scientific expertise and the integration of CP Kelco, which added pectins, gums and starches and access to new categories 1. Competition may come from suppliers offering similar reformulation solutions, though the source does not identify specific rivals 1.

    • Speciality food ingredient suppliers

      The source does not name specific competitors; competition comes from suppliers of food reformulation solutions 1.

    • Non-nutritive sweetener producers

      Competition in sweetening is described generically without company names in the source 1.

    • Dietary fibre suppliers

      Competition in fortification is not detailed in the source, which only gives market size 1.

    • Texturant suppliers (gums, pectins, starches)

      The source mentions this segment as part of the mouthfeel platform, with no named competitors 1.

    News & filings

    In the press

    Annual reports (ESEF)

    Sources

    1. [1] Annual report, fiscal year ended 2026-03-31 (ESEF) · SEC / Tate & Lyle PLC · 31 Mar 2026

    Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.

    Tate & Lyle PLC (TATE.L): stock, results, valuation and forecast · olivLaw